drugset / Trial / NCT00291356
GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
RandomizedSingle-groupDouble-blindTreatment
Summary
This is a study to compare the safety, blood concentrations, and effects of GSK189075, GW869682, and placebo when dosed for 2-weeks by mouth to patients with type 2 diabetes.
Timeline
- Start
- 2006-01
- Primary completion
- 2006-05
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GW869682 | Unknown | — | Oral |
| Subject | remogliflozin etabonate | Small molecule | — | Oral |